604 filings
Page 5 of 31
DEFA14A
o13eb
7 Jan 21
Additional proxy soliciting materials
4:32pm
8-K
7m2p8q7crmmqg37t3f59
7 Jan 21
PerkinElmer to Acquire Oxford Immunotec Global PLC
4:31pm
8-K
msdbs3uqxndx2o rt2
28 Oct 20
Revenue of $964.0 million; 36% reported growth; 34% organic growthGAAP EPS from continuing operations of $1.57; Adjusted EPS of $2.09
4:16pm
8-K
28szw2v0bljg20bo7w
13 Oct 20
Results of Operations and Financial Condition
6:02am
8-K
mztvd
28 Jul 20
Revenue of $811.7 million; 12% reported growth; 13% organic growthGAAP EPS from continuing operations of $1.23; Adjusted EPS of $1.57
4:42pm
8-K
sgixq38en3u wgl9w
13 Jul 20
Results of Operations and Financial Condition
8:09am
SD
ptj4lr
1 Jun 20
Conflict minerals disclosure
8:00am
8-K
1o7mw
5 May 20
Results of Operations and Financial Condition
4:35pm
8-K
xbe0m3tawf8b1lh
1 May 20
Submission of Matters to a Vote of Security Holders
4:06pm
DEFA14A
tk1ln41k7bv
14 Apr 20
Additional proxy soliciting materials
8:26am
8-K
xr2gjxg7
1 Apr 20
Restricted Stock Unit Agreement
4:05pm
8-K
t7p9jt6rj9i0
25 Mar 20
Regulation FD Disclosure
2:45pm
DEFA14A
m7sf qdj7xaz0xla8t8
11 Mar 20
Additional proxy soliciting materials
8:02am
8-K
wx4p9ut
9 Mar 20
PerkinElmer First Quarter 2020 Financial Performance Update
8:10am
8-K
c8cd8t7l5ffo75y3gp0
2 Mar 20
Departure of Directors or Certain Officers
4:05pm